Sanbox Reserved 684: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme [1] and has been shown to reduce ammonia intoxication in animal experiment. | A potential treatment for the high ammonia levels is to give sodium benzoate, which combines with glycine to produce hippurate, at the same time removing an ammonium group. Biotin also plays an important role in the functioning of the OTC enzyme [1] and has been shown to reduce ammonia intoxication in animal experiment. | ||
==== | ===='''Mechanism'''==== | ||
The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi. | The side chain amino group of Orn attacks the carbonyl carbon of CP nucleophillically, to form a tetrahedral transition state. A charge rearrangement then realeases Cit and Pi. | ||
N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). | N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate transition-state analog which competitively inhibits ornithine transcarbamylase (OTC) in vitro. Studies have also shown that N δ-(N′-sulfodiaminophosphinyl)-l-ornithine (PSOrn), with its three unique N-P bonds, represents a true transition state analogue for ornithine transcarbamoylases (OTC). | ||
